Rick Franklin
Chief Executive Officer at PATHFINDER CELL THERAPY, INC.
Profile
Richard L.
Franklin was the founder of DMS Data Systems LLC (founded in 2002) where he serves as Chairman from 2002 to 2013, Richard Franklin & Associates (founded in 1991) where he serves as Principal in 1996, Pathfinder LLC (founded in 2008) where he serves as Chairman, President & Chief Executive Officer in 2011, Tarix Pharmaceuticals Ltd.
(founded in 2004) where he previously serves as Chief Executive Officer & Director, and Pathfinder Cell Therapy, Inc. (founded in 2011) where he previously serves as President, Chief Executive Officer & Secretary.
Dr. Franklin is also the founder of Tarix Orphan LLC and Constant Therapeutics LLC.
He is currently working as a Director at Tarixcvm, LLC since 2014.
In his former positions, Dr. Franklin served as Chief Executive Officer & Director at Phairson Medical Ltd.
from 1996 to 2002, Executive Chairman at SyntheMed, Inc. in 2010, Director at Raptor Pharmaceuticals Corp., Independent Director at Horizon Pharmaceutical LLC from 2012 to 2016, and Head-Healthcare Corporate Finance at Tucker Anthony, Inc. from 1986 to 1987.
Dr. Franklin's education includes an undergraduate degree from Harvard University, a doctorate degree from Brandeis University, a graduate degree from the University of Wisconsin, and a doctorate degree from Boston University School of Medicine.
Rick Franklin active positions
Companies | Position | Start |
---|---|---|
PATHFINDER CELL THERAPY, INC. | Chief Executive Officer | 23/09/2011 |
Tarixcvm, LLC
Tarixcvm, LLC Pharmaceuticals: MajorHealth Technology Tarixcvm, LLC is a clinical stage company that develops pharmaceutical drugs. The private company is based in Cambridge, MA. | Director/Board Member | 01/06/2014 |
Tarix Orphan LLC
Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Founder | - |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Founder | 01/01/2004 |
Constant Therapeutics LLC | Founder | - |
Former positions of Rick Franklin
Companies | Position | End |
---|---|---|
RAPTOR PHARMACEUTICAL CORP | Director/Board Member | 25/10/2016 |
DMS Data Systems LLC
DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions. | Founder | 21/08/2013 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Chairman | 30/12/2010 |
Pathfinder LLC | Chief Executive Officer | 16/09/2011 |
░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Rick Franklin
Harvard University | Undergraduate Degree |
Brandeis University | Doctorate Degree |
University of Wisconsin | Graduate Degree |
Boston University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PATHFINDER CELL THERAPY, INC. | Health Technology |
Private companies | 12 |
---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
DMS Data Systems LLC
DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions. | Commercial Services |
Tucker Anthony, Inc. | Finance |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Health Technology |
Pathfinder LLC | Health Technology |
Richard Franklin & Associates | |
Phairson Medical Ltd.
Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | Commercial Services |
Tarix Orphan LLC
Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Health Technology |
Tarixcvm, LLC
Tarixcvm, LLC Pharmaceuticals: MajorHealth Technology Tarixcvm, LLC is a clinical stage company that develops pharmaceutical drugs. The private company is based in Cambridge, MA. | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Constant Therapeutics LLC |
- Stock Market
- Insiders
- Rick Franklin